Showing results (1-10 of 2,981) with videos related to
Sort By:
Pageof 299
Cardiovascular Drugs and Therapy|December 1, 1992
Effects of calcium channel agonism by Bay-K-8644 on ventricular fibrillation threshold of isolated heartM G Worthington, L H OpieCardiovascular Drugs and Therapy|September 17, 2003
Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromesCarlos V Serrano, José C Nicolau, Margareth Venturinelli, et al.Cardiovascular Drugs and Therapy|September 17, 2003
Recent developments in the treatment of type 2 diabetes mellitusLuis M RuilopeCardiovascular Drugs and Therapy|September 17, 2003
New approaches to overcome tolerance to nitratesMichael Schwemmer, Eberhard BassengeCardiovascular Drugs and Therapy|September 17, 2003
Evolution and cost trends of antihypertensive and hypolipidaemic drug treatment in FrancePedro Marques-Vidal, Michèle Montaye, Jean-Bernard Ruidavets, et al.Cardiovascular Drugs and Therapy|August 1, 1992
Effects of lobenzarit on murine acute viral myocarditisT Yokoyama, T Kanda, T Suzuki, et al.Cardiovascular Drugs and Therapy|June 15, 2022
Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 AxisJingquan Chen, Kun Lai, Xi Yong, et al.Cardiovascular Drugs and Therapy|February 3, 2011
Chronic istaroxime improves cardiac function and heart rate variability in cardiomyopathic hamstersPietro Lo Giudice, Giovan Giuseppe Mattera, Jean-Pierre Gagnol, et al.Cardiovascular Drugs and Therapy|December 1, 1990
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptorsE Müller-SchweinitzerCardiovascular Drugs and Therapy|June 1, 1990
In-vitro and in-vivo electrophysiologic effects of encainideC Libersa, J Caron, R RouetPageof 299